Acid suppression therapy impairs sunitinib efficacy in renal cell cancer (RCC)

被引：0
|
作者：
Chu, Michael P. [1 ]
Ha, Vincent [1 ]
Ngo, Margaret [2 ]
Ghosh, Sunita [1 ]
Chambers, Carole R. [2 ]
Sawyer, Michael B. [1 ]
机构：
[1] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[2] Tom Baker Canc Clin, Calgary, AB, Canada
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-4628
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4628
引用
收藏
页数：2
相关论文
共 50 条
  • [21] AN ANALYSIS OF RENAL CELL CARCINOMA (RCC) XENOGRAFT MODELS DEVELOPING RESISTANCE TO SUNITINIB
    Noboru, S.
    Tomomi, K.
    Toshinari, Y.
    Toru, K.
    Ryuichiro, A.
    Hiromasa, S.
    Takahiro, I
    Osamu, O.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 373 - 373
  • [22] Phase II efficacy and safety study of nintedanib versus sunitinib in previously untreated renal cell carcinoma (RCC) patients
    Eisen, Tim
    Shparyk, Yaroslav
    Jones, Robert
    MacLeod, Nicholas James
    Temple, Graham
    Finnigan, Helen
    Kaiser, Rolf
    Studeny, Matus
    Loembe, Arsene Bienvenu
    Bondarenko, Igor
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] Sunitinib versus sorafenib as first-line therapy followed by sorefenib and sunitinib for patients with metastatic renal cell carcinoma (RCC) with clear cell histology: A multicenter randomized trial, CROSS-J-RCC.
    Tomita, Yoshihiko
    Naito, Sei
    Sassa, Naoto
    Takahashi, Atsushi
    Kondo, Tsunenori
    Koie, Takuya
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [24] Safety and efficacy of targeted therapy for renal cell carcinoma (RCC) with brain metastasis.
    Bastos, Diogo Assed
    Molina, Ana M.
    Jia, Xiaoyu
    Velasco, Susanne
    Patil, Sujata
    Voss, Martin Henner
    Feldman, Darren Richard
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [25] Sunitinib as adjuvant therapy for renal cell carcinoma
    Baker, Holly
    LANCET ONCOLOGY, 2016, 17 (11): : E485 - E485
  • [26] Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer
    Yuasa, Takeshi
    Takahashi, Shunji
    Hatake, Kiyohiko
    Yonese, Junji
    Fukui, Iwao
    CANCER SCIENCE, 2011, 102 (11) : 1949 - 1957
  • [27] Sunitinib efficacy against advanced renal cell carcinoma
    Motzer, Robert J.
    Michaelson, M. Dror
    Rosenberg, Jonathan
    Bukowski, Ronald M.
    Curti, Brendan D.
    George, Daniel J.
    Hudes, Gary R.
    Redman, Bruce G.
    Margolin, Kim A.
    Wilding, George
    JOURNAL OF UROLOGY, 2007, 178 (05): : 1883 - 1887
  • [28] The safety and efficacy of sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer
    Powles, T.
    Kayani, I.
    Blank, C. U.
    Chowdhury, S.
    Horenblas, S.
    Sarwar, N.
    Nathan, P. D.
    Boleti, E.
    Haanen, J. B.
    Bex, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Patients with metastatic papillary renal cell carcinoma (RCC) who may benefit from sunitinib therapy (tx): Results from an international metastatic RCC database
    Lee, Jae-Lyun
    Gottfried, Maya
    Maimon, Natalie
    Hammers, Hans J.
    Eisenberger, Mario A.
    Carducci, Michael Anthony
    Sinibaidi, Victoria J.
    Neiman, Victoria
    Rosenbaum, Eli
    Sarid, David
    Gez, Eliahu
    Peer, Avivit
    Selia, Avishay
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Berger, Raanan
    Kelzman, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer
    Powles, T.
    Kayani, I.
    Blank, C.
    Chowdhury, S.
    Horenblas, S.
    Peters, J.
    Shamash, J.
    Sarwar, N.
    Boletti, K.
    Sadev, A.
    O'Brien, T.
    Berney, D.
    Beltran, L.
    Haanen, J.
    Bex, A.
    ANNALS OF ONCOLOGY, 2011, 22 (05) : 1041 - 1047
12345